Sleep apnea: What blood tests can add

What nighttime breathing pauses can set in motion

Repeated oxygen drops, known as intermittent hypoxia, and brief awakenings can activate the sympathetic nervous system. These responses help explain why obstructive sleep apnea, or OSA, is studied alongside inflammation, metabolic changes, and cardiovascular health. Blood markers can shed light on parts of that picture, but an individual result cannot tell us how much of a change was caused by apnea.

Research has examined inflammatory proteins such as C-reactive protein and interleukin-6 (CRP and IL-6), oxidative-stress markers such as 8-isoprostanes and malondialdehyde, and vascular signaling molecules such as endothelin-1. ICAM-1 and VCAM-1 are studied in relation to vascular activation; leptin and adiponectin relate to appetite and insulin sensitivity. Uric acid, fibrinogen, and PAI-1 have also been investigated. These are not interchangeable measurements, and this list is not a recommended routine panel for everyone with OSA.

BNP, NT-proBNP, and troponin have established uses for particular cardiac questions. They do not specifically identify cardiac stress caused by sleep apnea and should be ordered when the clinical situation warrants them. Likewise, a research association does not make a marker a validated measure of apnea severity or treatment success.

A sleep evaluation remains central. AASM guidance supports polysomnography or, for appropriately selected uncomplicated adults, a technically adequate home sleep apnea test. Blood tests cannot replace either approach.

Why blood testing may matter alongside a nighttime disorder

Sleep apnea is associated with cardiovascular and metabolic conditions that matter during the day as well as at night. Blood tests can help assess those accompanying risks. hs-CRP describes nonspecific inflammatory activity; a lipid profile measures cholesterol and triglycerides; glucose testing helps assess blood sugar regulation. Insulin measurements and calculated indices can be useful in research or selected clinical contexts, but they do not automatically establish why insulin resistance developed.

The underlying research offers meaningful signals. A meta-analysis of prospective cohorts linked moderate-to-severe OSA with a higher incidence of type 2 diabetes; its estimate for mild OSA was less certain. Reviews also describe differences in lipids and inflammatory markers between groups with and without OSA. Weight, medication, diet, and other factors overlap with these relationships, so the findings cannot attribute an individual’s blood results solely to interrupted breathing.

The commonly cited hs-CRP categories below 1, 1–3, and above 3 mg/L come from cardiovascular risk assessment. They are not apnea thresholds or direct measurements of inflammation inside blood vessels. Acute infection can raise CRP for a different reason. An apparently favorable result does not exclude important sleep apnea or establish that nighttime oxygen drops are harmless.

Higher LDL or non-HDL cholesterol and triglycerides can contribute to cardiovascular risk assessment. There is no special “middle” total-cholesterol target for apnea, and a high HDL result does not cancel out other risks. Glucose needs its own units and diagnostic context. Fasting plasma glucose of 100–125 mg/dL falls in the US prediabetes range; 126 mg/dL or higher may meet a diabetes criterion, with confirmation generally required unless hyperglycemia is unequivocal. These categories do not measure apnea severity. ADA diagnostic guidance

Low glucose can cause symptoms such as shaking or sweating and deserves assessment on its own terms. Unusually low lipids, differences around menopause, or glucose and insulin findings in children also require context rather than a one-size-fits-all interpretation. Normal glucose does not, by itself, establish normal insulin sensitivity.

Taken together with history, blood pressure, symptoms, and sleep testing, selected laboratory results can inform care for coexisting cardiovascular or metabolic concerns. They do not form a validated single panel that predicts stroke, fatty liver, pregnancy complications, or every other condition associated with OSA.

What blood tests cannot answer about sleep apnea

Sleep apnea can affect daytime energy, thinking, and broader health. The markers discussed here cover inflammation, lipids, glucose regulation, and the triglyceride-glucose index, or TyG. TyG is a calculated research marker related to insulin resistance; it is not an independent diagnostic test for apnea or a required addition to everyone’s care.

Unremarkable laboratory results may indicate a more favorable metabolic picture, but they do not rule out clinically important OSA. Conversely, abnormal results may have causes unrelated to apnea. Age, pregnancy, acute illness, medication, and laboratory methods influence interpretation. Any decision to test or retest should address a specific clinical question, rather than treating this article as a standard panel or schedule.

Frequently asked questions

What is a sleep apnea blood test?

There is no blood test in this article that diagnoses sleep apnea. The term refers to additional assessment of inflammation, cardiovascular risk, or glucose regulation where appropriate. hs-CRP, lipids, glucose, insulin, and TyG answer different questions and are not all routinely needed. Diagnosing the breathing disorder requires a suitable sleep evaluation and test.

Why might blood tests be useful?

They can help identify coexisting conditions, establish relevant baseline values, and follow specific treatment goals. For example, lipid or glucose results may affect cardiovascular or diabetes care. They complement a sleep study; they do not demonstrate that every abnormality is a downstream effect of OSA.

Can blood be collected at home?

Some healthcare providers arrange home collection by qualified staff. Collection, transport, and laboratory requirements should be clarified in advance. Nutrient Desk does not provide a blood collection service. A home blood draw is also different from a home sleep apnea test, which records sleep-related breathing signals.

How often are follow-up tests useful?

There is no universal annual or three-to-six-month blood-test schedule simply because someone has OSA. Timing depends on the particular condition being assessed, the initial result, medication, and whether a repeat measurement will change care. If inflammation is measured during an acute illness, a clinician may recommend reassessment after recovery. Monitoring apnea treatment itself also involves symptoms and appropriate sleep-related information.

What can affect the biomarkers?

Infection, injury, and inflammatory flares can raise hs-CRP. Fasting status, recent alcohol intake, exercise, and collection time can affect some glucose, insulin, or triglyceride measurements. Medication, smoking, stress, sleep, pregnancy, and other physiological factors may also contribute. The relevant influences differ by test; they are not identical across every marker.

Do hs-CRP, lipid, glucose, or insulin tests require preparation?

Follow the instructions for the actual tests ordered. Fasting plasma glucose requires a fast of at least eight hours; water is generally allowed. Many lipid assessments can be performed without fasting, while some clinical questions require a fasting sample. hs-CRP itself does not require a universal fasting protocol. Do not impose a blanket 24-hour ban on exercise or alcohol unless instructed for the particular assessment, and do not change medication on your own. Diabetes testing guidance

Can lifestyle changes affect the results?

Yes. Changes in weight, diet, activity, smoking, alcohol use, and sleep can influence inflammation and metabolic measurements. The size and timing of a response vary. Longer-term patterns are often more useful than one fluctuation, but improved blood results alone do not show that apnea has resolved. Continue the agreed sleep-apnea treatment and follow-up plan.

How should I interpret my results?

Interpret each marker for its established purpose. hs-CRP is nonspecific; LDL, non-HDL cholesterol, and triglycerides contribute to cardiovascular assessment; fasting glucose is interpreted using diabetes criteria and confirmation rules. Fasting insulin has no single universal cutoff that establishes insulin resistance across all assays and populations. Consider the results together with symptoms, history, and sleep testing, rather than using a favorable panel to dismiss breathing pauses or an unfavorable panel to diagnose them.

Sources and evidence

Jordan AS, McSharry DG, Malhotra A (2014). Adult obstructive sleep apnoea. Lancet, 383(9918), 736-747. https://doi.org/10.1016/S0140-6736(13)60734-5 Publication

Imani MM, Sadeghi M, Farokhzadeh F, Khazaie H, Brand S, Dürsteler KM, Brühl A, Sadeghi-Bahmani D (2021). Evaluation of blood levels of C-reactive protein marker in obstructive sleep apnea: A systematic review, meta-analysis and meta-regression. Life, 11(4), 362. https://doi.org/10.3390/life11040362 Publication

Wang X, Bi Y, Zhang Q, Pan F (2013). Obstructive sleep apnoea and the risk of type 2 diabetes: A meta-analysis of prospective cohort studies. Respirology, 18(1), 140-146. https://doi.org/10.1111/j.1440-1843.2012.02267.x Publication

Nadeem R, Singh M, Nida M, Waheed I, Khan A, Ahmed S, Naseem J, Champeau D (2014). Effect of obstructive sleep apnea hypopnea syndrome on lipid profile: A meta-regression analysis. Journal of Clinical Sleep Medicine, 10(5), 475-489. https://doi.org/10.5664/jcsm.3690 Publication

Peled N, Kassirer M, Shitrit D, Kogan Y, Shlomi D, Berliner AS, Kramer MR (2007). The association of OSA with insulin resistance, inflammation and metabolic syndrome. Respiratory Medicine, 101(8), 1696-1701. https://doi.org/10.1016/j.rmed.2007.02.025 Publication

Kapur VK et al. (2017). Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea. PubMed

American Diabetes Association (2026). Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026. https://doi.org/10.2337/dc26-s002

NIDDK. Diabetes Tests & Diagnosis. https://www.niddk.nih.gov/health-information/diabetes/overview/tests-diagnosis

Pearson TA et al. (2003). Markers of inflammation and cardiovascular disease: application to clinical and public health practice. PubMed